Micron Biomedical, Inc. — Form D
Micron Biomedical, Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-07. The offering totals $14.0M, of which $14.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-12-07
- Form: D
- Accession: 0000945621-22-000396
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.0M
- Amount sold: $14.0M
- Investors: 4
- Date of first sale: 2022-11-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466813
Issuer
- Name: Micron Biomedical, Inc.
- CIK: 0001957384
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 575 Fourteenth Street, NW, ATLANTA, GA, 30318
- Phone: 404-368-1554
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Steven Damon | Director | Atlanta, GA |
| Steven Damon | Executive Officer | Atlanta, GA |
| Sebastien Henry | Executive Officer | Atlanta, GA |
| Matthew Goldman | Director | San Francisco, CA |
| Labeeb Abboud | Director | New York, NY |
| Mark Prausnitz | Director | Cumming, GA |
| Henry Sebastien | Executive Officer | Atlanta, GA |
| Devin McAllister | Executive Officer | Atlanta, GA |
| Idean Marvasty | Executive Officer | Atlanta, GA |
| Brian Bernick | Director | Atlanta, GA |
| Bas Van Buijtenen | Director | Atlanta, GA |
| Steve Damon | Director | Atlanta, GA |
| Steve Damon | Executive Officer | Atlanta, GA |
Other filings by this issuer (2)
More